BioInform s 2003 Report Card: Half of Sector s 101 Software Firms in the Black | GenomeWeb

The bioinformatics software sector may be in better shape than you think it is. While the recent financial struggles of publicly traded bioinformatics firms have been well documented, it turns out that the performance of these firms is not representative of the sector as a whole: A recent BioInform survey found that more than half of the privately traded software companies in the space broke even or were profitable in 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.